Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials– This next-generation anthracycline demonstrates safety and promising early activity in treating multiple ...

Biotin deficiency is a medical condition resulting from insufficient biotin that can lead to various clinical manifestations ...

Annamycin consistently demonstrates no evidence of cardiotoxicity across five clinical trials - This next-generation anthracycline demonstrates safety and promising early activity in treating multiple ...

Biomarkers associated with cognitive impairment differ between men and women with chronic kidney disease, according to data ...

Cirrhotic cardiomyopathy (CCM) is a significant complication of cirrhosis, but its progression and underlying mechanisms remain incompletely ...

Weight management medications show limited long-term effects, with rapid weight regain post-treatment, emphasizing the need ...

Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well ...

Virtual reality and agetech devices were among the consumer electronics devices that caught the attention of U.S. Bank Chief ...

Modern smart collars have evolved from simple GPS trackers to sophisticated biometric instruments capable of early disease ...

Illumina, Inc. today introduced the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug ...

The noninvasive diagnosis of allograft rejection after heart transplantation may be on the horizon, according to findings ...